Dermatological Drugs Market, Global Outlook and Forecast 2022-2028

April 2022 | 79 pages | ID: DABC3FCE4AA9EN
Market Monitor Global

Abstracts

Dermatology is a field of medicine that is engaged in the diagnosis, prevention, and treatment of various skin, nails, hair diseases, pigmentation, acne, wrinkles, psoriasis, and others.

This report contains market size and forecasts of Dermatological Drugs in global, including the following market information:

Global Dermatological Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Dermatological Drugs Market Sales, 2017-2022, 2023-2028, (MT)

Global top five Dermatological Drugs companies in 2021 (%)

The global Dermatological Drugs market was valued at 25070 million in 2021 and is projected to reach US$ 34110 million by 2028, at a CAGR of 4.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Prescription-Based Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Dermatological Drugs include Johnson & Johnson, Merck, Bayer, Mylan Pharmaceuticals, Pfizer, F. Hoffmann-La Roche, Allergan, Valeant Pharmaceuticals and PharmaDerm Pharmaceuticals and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dermatological Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Dermatological Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Dermatological Drugs Market Segment Percentages, by Type, 2021 (%)

• Prescription-Based Drugs
• Over-the-Counter Drugs

Global Dermatological Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Dermatological Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Dermatological Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Dermatological Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Dermatological Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Dermatological Drugs revenues share in global market, 2021 (%)

Key companies Dermatological Drugs sales in global market, 2017-2022 (Estimated), (MT)

Key companies Dermatological Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Johnson & Johnson
• Merck
• Bayer
• Mylan Pharmaceuticals
• Pfizer
• F. Hoffmann-La Roche
• Allergan
• Valeant Pharmaceuticals
• PharmaDerm Pharmaceuticals
• Allergan Inamed Corporation

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Dermatological Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Dermatological Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DERMATOLOGICAL DRUGS OVERALL MARKET SIZE

2.1 Global Dermatological Drugs Market Size: 2021 VS 2028
2.2 Global Dermatological Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Dermatological Drugs Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Dermatological Drugs Players in Global Market
3.2 Top Global Dermatological Drugs Companies Ranked by Revenue
3.3 Global Dermatological Drugs Revenue by Companies
3.4 Global Dermatological Drugs Sales by Companies
3.5 Global Dermatological Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Dermatological Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Dermatological Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dermatological Drugs Players in Global Market
  3.8.1 List of Global Tier 1 Dermatological Drugs Companies
  3.8.2 List of Global Tier 2 and Tier 3 Dermatological Drugs Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Dermatological Drugs Market Size Markets, 2021 & 2028
  4.1.2 Prescription-Based Drugs
  4.1.3 Over-the-Counter Drugs
4.2 By Type - Global Dermatological Drugs Revenue & Forecasts
  4.2.1 By Type - Global Dermatological Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Dermatological Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Dermatological Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Dermatological Drugs Sales & Forecasts
  4.3.1 By Type - Global Dermatological Drugs Sales, 2017-2022
  4.3.2 By Type - Global Dermatological Drugs Sales, 2023-2028
  4.3.3 By Type - Global Dermatological Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Dermatological Drugs Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Dermatological Drugs Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Dermatological Drugs Revenue & Forecasts
  5.2.1 By Application - Global Dermatological Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Dermatological Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Dermatological Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Dermatological Drugs Sales & Forecasts
  5.3.1 By Application - Global Dermatological Drugs Sales, 2017-2022
  5.3.2 By Application - Global Dermatological Drugs Sales, 2023-2028
  5.3.3 By Application - Global Dermatological Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Dermatological Drugs Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Dermatological Drugs Market Size, 2021 & 2028
6.2 By Region - Global Dermatological Drugs Revenue & Forecasts
  6.2.1 By Region - Global Dermatological Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Dermatological Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Dermatological Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Dermatological Drugs Sales & Forecasts
  6.3.1 By Region - Global Dermatological Drugs Sales, 2017-2022
  6.3.2 By Region - Global Dermatological Drugs Sales, 2023-2028
  6.3.3 By Region - Global Dermatological Drugs Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Dermatological Drugs Revenue, 2017-2028
  6.4.2 By Country - North America Dermatological Drugs Sales, 2017-2028
  6.4.3 US Dermatological Drugs Market Size, 2017-2028
  6.4.4 Canada Dermatological Drugs Market Size, 2017-2028
  6.4.5 Mexico Dermatological Drugs Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Dermatological Drugs Revenue, 2017-2028
  6.5.2 By Country - Europe Dermatological Drugs Sales, 2017-2028
  6.5.3 Germany Dermatological Drugs Market Size, 2017-2028
  6.5.4 France Dermatological Drugs Market Size, 2017-2028
  6.5.5 U.K. Dermatological Drugs Market Size, 2017-2028
  6.5.6 Italy Dermatological Drugs Market Size, 2017-2028
  6.5.7 Russia Dermatological Drugs Market Size, 2017-2028
  6.5.8 Nordic Countries Dermatological Drugs Market Size, 2017-2028
  6.5.9 Benelux Dermatological Drugs Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Dermatological Drugs Revenue, 2017-2028
  6.6.2 By Region - Asia Dermatological Drugs Sales, 2017-2028
  6.6.3 China Dermatological Drugs Market Size, 2017-2028
  6.6.4 Japan Dermatological Drugs Market Size, 2017-2028
  6.6.5 South Korea Dermatological Drugs Market Size, 2017-2028
  6.6.6 Southeast Asia Dermatological Drugs Market Size, 2017-2028
  6.6.7 India Dermatological Drugs Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Dermatological Drugs Revenue, 2017-2028
  6.7.2 By Country - South America Dermatological Drugs Sales, 2017-2028
  6.7.3 Brazil Dermatological Drugs Market Size, 2017-2028
  6.7.4 Argentina Dermatological Drugs Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Dermatological Drugs Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Dermatological Drugs Sales, 2017-2028
  6.8.3 Turkey Dermatological Drugs Market Size, 2017-2028
  6.8.4 Israel Dermatological Drugs Market Size, 2017-2028
  6.8.5 Saudi Arabia Dermatological Drugs Market Size, 2017-2028
  6.8.6 UAE Dermatological Drugs Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Johnson & Johnson
  7.1.1 Johnson & Johnson Corporate Summary
  7.1.2 Johnson & Johnson Business Overview
  7.1.3 Johnson & Johnson Dermatological Drugs Major Product Offerings
  7.1.4 Johnson & Johnson Dermatological Drugs Sales and Revenue in Global (2017-2022)
  7.1.5 Johnson & Johnson Key News
7.2 Merck
  7.2.1 Merck Corporate Summary
  7.2.2 Merck Business Overview
  7.2.3 Merck Dermatological Drugs Major Product Offerings
  7.2.4 Merck Dermatological Drugs Sales and Revenue in Global (2017-2022)
  7.2.5 Merck Key News
7.3 Bayer
  7.3.1 Bayer Corporate Summary
  7.3.2 Bayer Business Overview
  7.3.3 Bayer Dermatological Drugs Major Product Offerings
  7.3.4 Bayer Dermatological Drugs Sales and Revenue in Global (2017-2022)
  7.3.5 Bayer Key News
7.4 Mylan Pharmaceuticals
  7.4.1 Mylan Pharmaceuticals Corporate Summary
  7.4.2 Mylan Pharmaceuticals Business Overview
  7.4.3 Mylan Pharmaceuticals Dermatological Drugs Major Product Offerings
  7.4.4 Mylan Pharmaceuticals Dermatological Drugs Sales and Revenue in Global (2017-2022)
  7.4.5 Mylan Pharmaceuticals Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Dermatological Drugs Major Product Offerings
  7.5.4 Pfizer Dermatological Drugs Sales and Revenue in Global (2017-2022)
  7.5.5 Pfizer Key News
7.6 F. Hoffmann-La Roche
  7.6.1 F. Hoffmann-La Roche Corporate Summary
  7.6.2 F. Hoffmann-La Roche Business Overview
  7.6.3 F. Hoffmann-La Roche Dermatological Drugs Major Product Offerings
  7.6.4 F. Hoffmann-La Roche Dermatological Drugs Sales and Revenue in Global (2017-2022)
  7.6.5 F. Hoffmann-La Roche Key News
7.7 Allergan
  7.7.1 Allergan Corporate Summary
  7.7.2 Allergan Business Overview
  7.7.3 Allergan Dermatological Drugs Major Product Offerings
  7.7.4 Allergan Dermatological Drugs Sales and Revenue in Global (2017-2022)
  7.7.5 Allergan Key News
7.8 Valeant Pharmaceuticals
  7.8.1 Valeant Pharmaceuticals Corporate Summary
  7.8.2 Valeant Pharmaceuticals Business Overview
  7.8.3 Valeant Pharmaceuticals Dermatological Drugs Major Product Offerings
  7.8.4 Valeant Pharmaceuticals Dermatological Drugs Sales and Revenue in Global (2017-2022)
  7.8.5 Valeant Pharmaceuticals Key News
7.9 PharmaDerm Pharmaceuticals
  7.9.1 PharmaDerm Pharmaceuticals Corporate Summary
  7.9.2 PharmaDerm Pharmaceuticals Business Overview
  7.9.3 PharmaDerm Pharmaceuticals Dermatological Drugs Major Product Offerings
  7.9.4 PharmaDerm Pharmaceuticals Dermatological Drugs Sales and Revenue in Global (2017-2022)
  7.9.5 PharmaDerm Pharmaceuticals Key News
7.10 Allergan Inamed Corporation
  7.10.1 Allergan Inamed Corporation Corporate Summary
  7.10.2 Allergan Inamed Corporation Business Overview
  7.10.3 Allergan Inamed Corporation Dermatological Drugs Major Product Offerings
  7.10.4 Allergan Inamed Corporation Dermatological Drugs Sales and Revenue in Global (2017-2022)
  7.10.5 Allergan Inamed Corporation Key News

8 GLOBAL DERMATOLOGICAL DRUGS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Dermatological Drugs Production Capacity, 2017-2028
8.2 Dermatological Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Dermatological Drugs Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 DERMATOLOGICAL DRUGS SUPPLY CHAIN ANALYSIS

10.1 Dermatological Drugs Industry Value Chain
10.2 Dermatological Drugs Upstream Market
10.3 Dermatological Drugs Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Dermatological Drugs Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Dermatological Drugs in Global Market
Table 2. Top Dermatological Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Dermatological Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Dermatological Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Dermatological Drugs Sales by Companies, (MT), 2017-2022
Table 6. Global Dermatological Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Dermatological Drugs Price (2017-2022) & (USD/MT)
Table 8. Global Manufacturers Dermatological Drugs Product Type
Table 9. List of Global Tier 1 Dermatological Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dermatological Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Dermatological Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Dermatological Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Dermatological Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Dermatological Drugs Sales (MT), 2017-2022
Table 15. By Type - Global Dermatological Drugs Sales (MT), 2023-2028
Table 16. By Application – Global Dermatological Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Dermatological Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Dermatological Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Dermatological Drugs Sales (MT), 2017-2022
Table 20. By Application - Global Dermatological Drugs Sales (MT), 2023-2028
Table 21. By Region – Global Dermatological Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Dermatological Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Dermatological Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Dermatological Drugs Sales (MT), 2017-2022
Table 25. By Region - Global Dermatological Drugs Sales (MT), 2023-2028
Table 26. By Country - North America Dermatological Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Dermatological Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Dermatological Drugs Sales, (MT), 2017-2022
Table 29. By Country - North America Dermatological Drugs Sales, (MT), 2023-2028
Table 30. By Country - Europe Dermatological Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Dermatological Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Dermatological Drugs Sales, (MT), 2017-2022
Table 33. By Country - Europe Dermatological Drugs Sales, (MT), 2023-2028
Table 34. By Region - Asia Dermatological Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Dermatological Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Dermatological Drugs Sales, (MT), 2017-2022
Table 37. By Region - Asia Dermatological Drugs Sales, (MT), 2023-2028
Table 38. By Country - South America Dermatological Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Dermatological Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Dermatological Drugs Sales, (MT), 2017-2022
Table 41. By Country - South America Dermatological Drugs Sales, (MT), 2023-2028
Table 42. By Country - Middle East & Africa Dermatological Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Dermatological Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Dermatological Drugs Sales, (MT), 2017-2022
Table 45. By Country - Middle East & Africa Dermatological Drugs Sales, (MT), 2023-2028
Table 46. Johnson & Johnson Corporate Summary
Table 47. Johnson & Johnson Dermatological Drugs Product Offerings
Table 48. Johnson & Johnson Dermatological Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 49. Merck Corporate Summary
Table 50. Merck Dermatological Drugs Product Offerings
Table 51. Merck Dermatological Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 52. Bayer Corporate Summary
Table 53. Bayer Dermatological Drugs Product Offerings
Table 54. Bayer Dermatological Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 55. Mylan Pharmaceuticals Corporate Summary
Table 56. Mylan Pharmaceuticals Dermatological Drugs Product Offerings
Table 57. Mylan Pharmaceuticals Dermatological Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 58. Pfizer Corporate Summary
Table 59. Pfizer Dermatological Drugs Product Offerings
Table 60. Pfizer Dermatological Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 61. F. Hoffmann-La Roche Corporate Summary
Table 62. F. Hoffmann-La Roche Dermatological Drugs Product Offerings
Table 63. F. Hoffmann-La Roche Dermatological Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 64. Allergan Corporate Summary
Table 65. Allergan Dermatological Drugs Product Offerings
Table 66. Allergan Dermatological Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 67. Valeant Pharmaceuticals Corporate Summary
Table 68. Valeant Pharmaceuticals Dermatological Drugs Product Offerings
Table 69. Valeant Pharmaceuticals Dermatological Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 70. PharmaDerm Pharmaceuticals Corporate Summary
Table 71. PharmaDerm Pharmaceuticals Dermatological Drugs Product Offerings
Table 72. PharmaDerm Pharmaceuticals Dermatological Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 73. Allergan Inamed Corporation Corporate Summary
Table 74. Allergan Inamed Corporation Dermatological Drugs Product Offerings
Table 75. Allergan Inamed Corporation Dermatological Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 76. Dermatological Drugs Production Capacity (MT) of Key Manufacturers in Global Market, 2020-2022 (MT)
Table 77. Global Dermatological Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Dermatological Drugs Production by Region, 2017-2022 (MT)
Table 79. Global Dermatological Drugs Production by Region, 2023-2028 (MT)
Table 80. Dermatological Drugs Market Opportunities & Trends in Global Market
Table 81. Dermatological Drugs Market Drivers in Global Market
Table 82. Dermatological Drugs Market Restraints in Global Market
Table 83. Dermatological Drugs Raw Materials
Table 84. Dermatological Drugs Raw Materials Suppliers in Global Market
Table 85. Typical Dermatological Drugs Downstream
Table 86. Dermatological Drugs Downstream Clients in Global Market
Table 87. Dermatological Drugs Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Dermatological Drugs Segment by Type
Figure 2. Dermatological Drugs Segment by Application
Figure 3. Global Dermatological Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Dermatological Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Dermatological Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Dermatological Drugs Sales in Global Market: 2017-2028 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Dermatological Drugs Revenue in 2021
Figure 9. By Type - Global Dermatological Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Dermatological Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Dermatological Drugs Price (USD/MT), 2017-2028
Figure 12. By Application - Global Dermatological Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Dermatological Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Dermatological Drugs Price (USD/MT), 2017-2028
Figure 15. By Region - Global Dermatological Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Dermatological Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Dermatological Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Dermatological Drugs Sales Market Share, 2017-2028
Figure 19. US Dermatological Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Dermatological Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Dermatological Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Dermatological Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Dermatological Drugs Sales Market Share, 2017-2028
Figure 24. Germany Dermatological Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Dermatological Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Dermatological Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Dermatological Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Dermatological Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Dermatological Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Dermatological Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Dermatological Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Dermatological Drugs Sales Market Share, 2017-2028
Figure 33. China Dermatological Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Dermatological Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Dermatological Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Dermatological Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Dermatological Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Dermatological Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Dermatological Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Dermatological Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Dermatological Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Dermatological Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Dermatological Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Dermatological Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Dermatological Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Dermatological Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Dermatological Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Dermatological Drugs Production Capacity (MT), 2017-2028
Figure 49. The Percentage of Production Dermatological Drugs by Region, 2021 VS 2028
Figure 50. Dermatological Drugs Industry Value Chain
Figure 51. Marketing Channels